Lv32
320 积分 2023-05-18 加入
Inhibition of B cell receptor-mediated activation of primary human B cells by coengagement of CD19 and FcγRIIb with Fc-engineered antibodies
10小时前
待确认
Trends in the drug target landscape for autoimmune diseases
23小时前
求助中
SKY59, A Novel Recycling Antibody for Complement-mediated Diseases
4天前
已完结
Selection of Payloads for Antibody–Drug Conjugates Targeting Ubiquitously Expressed Tumor-Associated Antigens: a Case Study
9天前
已完结
Development and Characterization of a Lysosome-Targeting SLC3A2/PD-L1 Bispecific Antibody-Drug Conjugate for Enhanced Anti-Tumor Efficacy in Solid Tumors
1个月前
已完结
Targeting IL-6 trans-signalling: past, present and future prospects
1个月前
已完结
Protein degraders push into novel target space
2个月前
已完结
Extracellular targeted protein degradation: an emerging modality for drug discovery
2个月前
已完结
MA07.06 Eradicating Drug Tolerant Persisters (DTPs) In EGFR-Mutated Non Small Cell Lung Cancer (NSCLC) By Targeting TROP2
2个月前
已关闭
The B7:CD28 family and friends: Unraveling coinhibitory interactions
2个月前
已完结
The Underlying Mechanism of 3-Hydroxyphthalic Anhydride-Modified Bovine Beta-Lactoglobulin to Block Human Papillomavirus Entry Into the Host Cell
皖公网安备34019202002308
